Abstract:BACKGROUND: Leptin and its receptor express in many central and peripheral sites, have various biological functions, and greatly affect bone metabolism. However, the mechanism of leptin effects on bone reconstruction is still unclear. OBJECTIVE: To observe the effects of leptin on differentiation of bone marrow mesenchymal stem cells (BMSCs) into osteoblasts. DESIGN, TIME AND SETTING: The cytological, in vitro, study was performed at the Laboratory of the Department of Biochemistry and Molecular Biology, Shanxi Medical University from March to September 2008. MATERIALS: Iliac bone marrow from healthy volunteers was obtained from the Second Hospital, Shanxi Medical University. Leptin (Sigma, USA) was used in this study. METHODS: Normal human BMSCs were isolated and cultured by the whole bone marrow method. Cells of the third passage at 1 × 108/L were incubated on coverslip in a 6-well plate, and randomly divided into 3 groups: osteogenic induction group, which was added with primary medium and osteogenic inducer, supplemented with 10 -8 mol/L dexamethasone, 10 mmol/L β-phosphoglycerol and 50 mg/L vitamin C; leptin osteogenic induction group was added with 50 nmol/l leptin in addition to osteogenic inducer. Cells in the blank control group were only treated with LG-DMEM containing 10% fetal bovine serum. MAIN OUTCOME MEASURES: The following parameters were measured: surface marker expression of BMSCs; results of calcified nodules staining; activity of alkaline phosphatase; contents of collagen-I and osteocalcin; expression of osteoprotegerin and RANKL protein. RESULTS: Positive rate of CD44 and CD71 were respectively 95.21% and 72.31% in BMSCs at passage 3, but positive rate of CD34 was only 0.39%. Von Kossa staining showed brown extracellular matrix calcium salt deposition at 21 days following osteogenic induction. Compared with the blank control group, activity of alkaline phosphatase; contents of collagen-I and osteocalcin were significantly increased in the osteogenic induction and leptin osteogenic induction groups at 14 days (P < 0.05). The increase of each index in the leptin osteogenic induction group was significantly higher than in the osteogenic induction group (P < 0.05). Compared with the osteogenic induction group, osteoprotegerin expression was significantly upregulated in the leptin osteogenic induction group (P < 0.05), but RANKL protein expression was significantly dowregulated (P < 0.05). CONCLUSION: Leptin could improve osteogenic differentiation of human BMSCs, and regulate bone metabolism through osteoprotegerin/RANK way.

Leptin promotes ossification through multiple ways of bone metabolism in osteoblast: a pilot study.

Isoalantolactone Inhibits RANKL-induced Osteoclast Formation Via Multiple Signaling Pathways

Alpinetin Inhibits RANKL-Induced Osteoclastogenesis and Ovariectomy-Induced Bone Loss by Modulating NFATc1 Transcription and Lysosomal Function

Leptin can promote mineralization and up-regulate RANKL mRNA expression in osteoblasts from adult female SD rats.

Increased osteogenesis in osteoporotic bone marrow stromal cells by overexpression of leptin

Combined use of leptin and mechanical stress has osteogenic effects on ossification of the posterior longitudinal ligament

Leptin promotes the osteoblastic differentiation of vascular smooth muscle cells from female mice by increasing RANKL expression.

Effect of Pilose Antler Oyster Chinese Medicine Compound on Protein Expression of Leptin in Bone Tissues of Ovariectomized Osteoporosis Rats

Effects of leptin on differentiation of bone marrow mesenchymal stem cells into osteoblasts

Osteoporosis and Leptin: A Systematic Review

Leptin attenuates the osteogenic induction potential of BMP9 by increasing β-catenin malonylation modification via Sirt5 down-regulation

Bone biomarkers of ovariectomised rats after leptin therapy

Anti-osteoporosis mechanism of resistance exercise in ovariectomized rats based on transcriptome analysis: a pilot study

IL-6 and Leptin Are Potential Biomarkers for Osteoporotic Fracture Risk Assessment and Prediction of Postmenopausal Women with Low Bone Mass: A Follow-Up Study Using a Regional Sample Cohort

The mechanism of oxytocin and its receptors in regulating cells in bone metabolism

The Role of Estrogen Receptor in Response to Longitudinal Bone Growth in ob/ob Mice

The Role of Estrogen Receptor α in Response to Longitudinal Bone Growth in ob/ob Mice

Effects of the Multifunctional Hormone Leptin on Orthodontic Tooth Movement in Rats.

Raloxifene inhibits bone loss and improves bone strength through an Opg-independent mechanism

[Effect of Estrogen on Osteoprotegerin, Osteoclast Differentiation Factor and Macrophage Colony Stimulating Factor Mrna Expressions in Ovariectomized Rat Bone Tissue].

Osteogenic Potential and Responsiveness to Leptin of Mesenchymal Stem Cells Between Postmenopausal Women with Osteoarthritis and Osteoporosis.